Jean MacFadyen
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 0.1%
- Lipoproteins and Cardiovascular Health
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 14
- Co-authors
- Paul M. RidkerRobert J. GlynnPeter LibbyWolfgang KöenigJacques GenestEleanor DanielsonFrancisco Antônio Helfenstein FonsecaBørge G. Nordestgaard
- Journals
- European Heart Journal (8 papers)Journal of the American College of Cardiology (6 papers)The Lancet (4 papers)Circulation (3 papers)Clinical Chemistry (3 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Jean MacFadyen
56 papers receiving 14.8k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Endocrinology, Diabetes and Metabolism 3.3k
- Surgery 8.1k
- Cardiology and Cardiovascular Medicine 4.1k
- Internal Medicine 481
- Immunology 2.3k
Countries citing papers authored by Jean MacFadyen
This map shows the geographic impact of Jean MacFadyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean MacFadyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean MacFadyen more than expected).
Fields of papers citing papers by Jean MacFadyen
This network shows the impact of papers produced by Jean MacFadyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean MacFadyen. The network helps show where Jean MacFadyen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jean MacFadyen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2023 | 10 | |
| 3 | 2022 | 80 | |
| 4 | 2020 | 222 | |
| 5 | 2020 | 139 | |
| 6 | 2018 | 206 | |
| 7 | 2014 | 48 | |
| 8 | 2013 | 43 | |
| 9 | 2012 | 10 | |
| 10 | 2012 | 2 | |
| 11 | 2012 | 126 | |
| 12 | Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial Hit paper breakdown → | 2012 | 562 |
| 13 | The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease Hit paper breakdown → | 2011 | 387 |
| 14 | 2011 | 116 | |
| 15 | 2010 | 121 | |
| 16 | 2010 | 155 | |
| 17 | 2010 | 187 | |
| 18 | Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein Hit paper breakdown → | 2009 | 2948 |
| 19 | A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism Hit paper breakdown → | 2009 | 543 |
| 20 | Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Hit paper breakdown → | 2008 | 4712 |
About Jean MacFadyen
Jean MacFadyen is a scholar working on Endocrinology, Diabetes and Metabolism, Internal Medicine, Surgery, Biochemistry and Cardiology and Cardiovascular Medicine, having authored 56 papers that have together received 15.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Adipokines, Inflammation, and Metabolic Diseases (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Inflammasome and immune disorders (8 papers), Cancer, Lipids, and Metabolism (6 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Acute Myocardial Infarction Research (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.3k citations), Surgery (8.1k citations), Cardiology and Cardiovascular Medicine (4.1k citations), Internal Medicine (481 citations) and Immunology (2.3k citations). Jean MacFadyen has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Paul M. Ridker, Robert J. Glynn, Peter Libby, Wolfgang Köenig, Jacques Genest, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, Børge G. Nordestgaard, John J.P. Kastelein and Antonio M. Gotto. Their work appears in journals such as European Heart Journal, Journal of the American College of Cardiology, The Lancet, Circulation and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.